Primary Analysis of ZUMA-2 Cohort 3: Brexucabtagene Autoleucel (Brexu-Cel) in Patients (pts) with Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL) Who Were Naive to Bruton Tyrosine Kinase Inhibitors (Btki) Tom van Meerten,M.J. Kersten,Gloria Iacoboni,Georg Hess, Pim Mutsaers, Alejandro Martín García-Sancho,Andre Goy,Eva Gine, Brian T. Hill,Wen-Kai Weng,Martin Dreyling, Patrick M. Reagan,Krish Patel,Ahmed Galal, Charles Herbaux,Robin Sanderson, Dan Zheng, Justyna Kanska, Wangshu Zhang, Rita Damico Khalid,Ioana Kloos,Michael WangBlood（2024）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
